Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders.
Wilson SE.
J Ocul Pharmacol Ther. 2023 Apr;39(3):191-206. doi: 10.1089/jop.2022.0174. Epub 2023 Mar 6.
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.
Schmidt E, Rashid H, Marzano AV, Lamberts A, Di Zenzo G, Diercks GFH, Alberti-Violetti S, Barry RJ, Borradori L, Caproni M, Carey B, Carrozzo M, Cianchini G, Corrà A, Dikkers FG, Feliciani C, Geerling G, Genovese G, Hertl M, Joly P, Meijer JM, Mercadante V, Murrell DF, Ormond M, Pas HH, Patsatsi A, Rauz S, van Rhijn BD, Roth M, Setterfield J, Zillikens D, C Prost, Zambruno G, Horváth B, Caux F.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):1926-1948. doi: 10.1111/jdv.17395. Epub 2021 Jul 26.
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.
Rashid H, Lamberts A, Borradori L, Alberti-Violetti S, Barry RJ, Caproni M, Carey B, Carrozzo M, Caux F, Cianchini G, Corrà A, Diercks GFH, Dikkers FG, Di Zenzo G, Feliciani C, Geerling G, Genovese G, Hertl M, Joly P, Marzano AV, Meijer JM, Mercadante V, Murrell DF, Ormond M, Pas HH, Patsatsi A, Prost C, Rauz S, van Rhijn BD, Roth M, Schmidt E, Setterfield J, Zambruno G, Zillikens D, Horváth B.
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):1750-1764. doi: 10.1111/jdv.17397. Epub 2021 Jul 10.
Immunology of the eye.
Bielory L.
Allergy Proc. 1991 Nov-Dec;12(6):365-9. doi: 10.2500/108854191779114275.
Evaluation of Dry Eye Severity and Ocular Surface Inflammation in Patients with Pemphigus and Pemphigoid.
Feng J, Liu Y, Ren Y, Shi W, Kang H, Tan Y, Wu R, Zhang G, He Y.
Ocul Immunol Inflamm. 2024 Jan;32(1):62-70. doi: 10.1080/09273948.2022.2154680. Epub 2023 Jan 13.
[Clinical aspects of ocular mucosal pemphigoid].
Roth M, Yaici R, Geerling G.
Ophthalmologie. 2023 May;120(5):472-477. doi: 10.1007/s00347-023-01854-0. Epub 2023 Apr 24.
Dermatological adverse effects of anti-glaucoma eye drops: a review.
Patchinsky A, Petitpain N, Gillet P, Angioi-Duprez K, Schmutz JL, Bursztejn AC.
J Eur Acad Dermatol Venereol. 2022 May;36(5):661-670. doi: 10.1111/jdv.17928. Epub 2022 Feb 11.
[Treatment of ocular mucous membrane pemphigoid].
Geerling G, Yaici R, Roth M.
Ophthalmologie. 2023 May;120(5):496-501. doi: 10.1007/s00347-023-01869-7. Epub 2023 Apr 25.
[Initial results of the German ocular pemphigoid register].
Yaïci R, Roth M, Geerling G.
Ophthalmologie. 2023 May;120(5):502-507. doi: 10.1007/s00347-023-01859-9. Epub 2023 Apr 28.
Prospective study of ocular manifestations of pemphigus and bullous pemphigoid identifies a high prevalence of dry eye syndrome.
Tan JC, Tat LT, Francis KB, Mendoza CG, Murrell DF, Coroneo MT.
Cornea. 2015 Apr;34(4):443-8. doi: 10.1097/ICO.0000000000000335.
